Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis

Journal of Investigative Dermatology

Volumn 129, Issue 7, 2009, Pages 1824-1835

  Hatano, Yutaka ^a,b   Man, Mao Qiang ^a,b   Uchida, Yoshikazu ^a,b   Crumrine, Debra ^a,b   Scharschmidt, Tiffany C ^a,b   Kim, Esther G ^a,b   Mauro, Theodora M ^a,b   Feingold, Kenneth R ^a,b   Elias, Peter M ^a,b,d   Holleran, Walter M ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CLOBETASOL; CYTOKINE; HAPTEN; IMMUNOGLOBULIN E; INTERLEUKIN 1ALPHA; LACTOBIONIC ACID; OXAZOLONE; TETRAHYDROLIPSTATIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ACIDIFICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CELL DENSITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ELECTRON MICROSCOPY; EOSINOPHIL; EPIDERMIS HYPERPLASIA; FEMALE; HAIRLESS MOUSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PH; PRIORITY JOURNAL; STRATUM CORNEUM; TH2 CELL; ZYMOGRAPHY;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DISACCHARIDES; EPIDERMIS; FEMALE; HAPTENS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN E; LIPID BILAYERS; MICE; MICE, HAIRLESS; OXAZOLONE; SERINE ENDOPEPTIDASES; TH2 CELLS;

EID: 67449136333     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.444     Document Type: Article

References (49)

1. Behne MJ, Barry NP, Hanson KM, Aronchik I, Clegg RW, Gratton E et al. (2003) Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function. J Invest Dermatol 120:998-1006
2. Behne MJ, Meyer JW, Hanson KM, Barry NP, Murata S, Crumrine D et al. (2002) NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J Biol Chem 277:473994-06
3. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW et al. (2002 Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47:198-208
4. Choi EH, Man MQ, Wang F, Zhang X, Brown BE, Feingold KR et al. (2005) Is endogenous glycerol a determinant of stratum corneum hydration in humans? Invest Dermatol 125:288-93
5. Choi EH, Man MQ, Xu P, Xin S, Liu Z, Crumrine DA et al. (2007a) Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol 127:2847-56
6. Choi EH, Man MQ, Xu P, Xin S, Liu Z, Crumrine DA et al. (2007b) Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol 127:2847-56
7. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacCowan A et al. (2006) New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118:3-21; quiz 22-3
8. Demerjian M, Hachem JP, Tschachler E, Denecker C, Declercq W, Vandenabeele P et al. (2008) Acute modulations in permeability barrier function regulate epidermal comification: role of caspase 14 and the protease activated receptor type 2. Am J Path 172:86-97
9. Demerjian M, Man MQ, Choi EH, Brown BE, Crumrine D, Chang S et al. (2006) Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol 15:154-60
10. Di Nardo A, Wertz P, Giannetti A, Seidenari S (1998) Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78:27-30
11. Elias P, Hatano Y, Williams M (2008) Basis for the barrier abnormality in atopic dermatitis: "outside-inside-outside" pathogenic mechanisms. J Allergy Clin Immunol 121:1337-43
12. Elias PM (2005) Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125:183-200
13. Elias PM (2007) The skin barrier as an innate immune element. Sem lmmunopath 29:3-14
14. Elias PM, Wood LC, Feingold KR (1999) Epidermal pathogenesis of inflammatory dermatoses. Am I Contact Dermat 10:119-26
15. Fartasch M (1997) Epidermal barrier in disorders of the skin. Microsc Res Tech 38:361-72
16. Fluhr JW, Crumrine D, Mao-Qiang M, Moskowitz DC, Elias PM, Feingold KR (2005) Topical liver X receptor activators accelerate postnatal acidification of stratum corneum and improve function in the neonate. J Invest Dermatol 125:1206-14
17. Fluhr JW, Elias PM (2002) Stratum corneum pH: formation and function of the "acid mantle". Exog Dermatol 1:163-75
18. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM (2001) Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. I Invest Dermatol 117:44-51
19. Fluhr JW, Mao-Qiang M, Brown BE, Hachem JP, Moskowitz DC, Demerjian M et al. (2004) Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol 123:140-51
20. Fluhr JW, Man MQ, Hachem JP, Crumrine D, Mauro TM, Elias PM, et al. (2008) Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification. J Invest Dermatol 179:365-74
21. Fowler AJ, Sheu MY, Schmuth M, Kao J, Fluhr JW, Rhein L et al. (2003) Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 120:246-55
22. Gunathilake R, Schurer N, Shoo B, Celli A, Hachem JP, Crumrine D, et al. (2009) pH-regulated mechanisms account for pigment type differences in epidermal barrier function. J Invest Dermatol (in press)
23. Hachem JP, Behne M, Aronchik I, Demerjian M, Feingold KR, Elias PM et al. (2005a) Extracellular pH Controls NHE1 expression in epidermis and keratinocytes: implications for barrier repair. J Invest Dermatol 125:790-7
24. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM (2003) pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121: 345-53
25. Hachem JP, Fowler A, Behne M, Fluhr J, Feingold K, Elias P (2002) Increased stratum corneum pH promotes activation and release of primary cytokines from the stratum corneum attributable to activation of serine proteases. J Invest Dermatol 119:258 (abstract)
26. Hachem JP, Houben E, Crumrine D, Man MQ, Schurer N, Roelandt T et al. (2006a) Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 126:2074-86
27. Hachem JP, Man MQ, Crumrine D, Uchida Y, Brown BE, Rogiers V et al. (2005b) Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 125:510-20
28. Hachem J-P, Roelandt T, Schurer N, Pu X, Fluhr J, Guiddelo C, et al. (2009) Acute acidification of stratum corneum membrane domains using polyhydroxyl acids improves lipid processing and inhibits degradation of corneodesmosomes. J Invest Dermatol (in press)
29. Hachem JP, Wagberg F, Schmuth M, Crumrine D, Lissens W, Jayakumar A et al. (2006b) Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126:1609-21
30. Hochuli E, Kupfer E, Maurer R, Meister W, Mercadal Y, Schmidt K (1987 Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation. J Antibiot (Tokyo) 40:1086-91
31. Holleran WM, Takagi Y, Uchida Y (2006) Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 580: 5456-66
32. Hou SY, Mitra AK, White SH, Menon GK, Ghadially R, Elias PM (1991) Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and X-ray diffraction. J Invest Dermatol 96:215-23
33. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96:523-6
34. Korting HC, Hubner K, Greiner K, Hamm G, Braun-Falco O (1990) Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol 70:429-31
35. Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR et al. (2008) Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 128:79-86
36. Mauro T, Holleran WM, Grayson S, Gao WN, Man MQ, Kriehuber E et al. (1998) Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 290:215-22
37. Melnik B, Hollmann J, Plewig G (1988) Decreased stratum corneum ceramides in atopic individuals-a pathobiochemical factor in xerosis? Br J Dermatol 119:547-9
38. Menon GK, Ghadially R, Williams ML, Elias PM (1992) Lamellar bodies as delivery systems of hydrolytic enzymes: implications for normal and abnormal desquamation. Br J Dermatol 126:337-45
39. Nagata T, Murata F (1972) Supplemental studies on the method for electron microscopic demonstration of lipase in the pancreatic acinar cells of mice and rats. Histochemie 29:8-15
40. Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-46
41. Nylander-Lundqvist E, Egelrud T (1997) Formation of active IL-I beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol 77:203-6
42. Rassner UA, Crumrine DA, Nau P, Elias PM (1997) Microwave incubation improves lipolytic enzyme preservation for ultrastructural cytochemistry. Histochem J 29:387-92
43. Schade H (1928) Zur physikalischen chemie der hautoberflache. Arch Dermatol Syphilis 154:690-716
44. Sheu MY, Fowler AJ, Kao J, Schmuth M, Schoonjans K, Auwerx J et al. (2002) Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 118:94-101
45. Taieb A (1999) Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 41:177-80
46. Takagi Y, Kriehuber E, Imokawa G, Elias PM, Holleran WM (1999) Betaglucocerebrosidase activity in mammalian stratum corneum. J Lipid Res 40:861-9
47. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR (1994a) Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-8
48. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C (1994b) Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol 3:56-60
49. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-7